Key Metrics of Vivos Therapeutics Inc.
Revenue$13.8M▼ 13.9% YoYFY 2023
Operating income−$17.3M▲ 30.9% YoY
Net profit−$13.6M▲ 43.0% YoY
Shareholders' equity$411K
Market cap$4.1MVVOS · $0.12
Competitors10identified
About Vivos Therapeutics Inc.
Sectors
Company details
- Founded
- 2020
- Listed
- Nasdaq: VVOS (since 2020)
Operational Areas of Vivos Therapeutics Inc.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameVivos Therapeutics Inc.
TickerVVOS
ExchangeNasdaq
CountryUnited States
SEC CIK0001716166
Listed since2020
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
VVOS · Nasdaq · SEC CIK 0001716166
Last price · 30 Oct 2026
$0.12
−1.07%
Market cap$4.1M
P/E—On FY 2023 diluted EPS
Volume1,253,257
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited StatesListed 2020
VVOS share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Vivos Therapeutics Inc.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Similar companies
H
Healthcare Realty Trust IncorporatedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
P
PACS Group Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Oscar Health Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
B
BrightSpring Health Services Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
A
American Healthcare REIT Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
O
Omega Healthcare Investors Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
K
Koninklijke Philips N.V. NY Registry SharesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
L
Labcorp Holdings Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.